The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma

被引:31
作者
Alexandrakis, MG
Passam, FH
Dambaki, C
Pappa, CA
Stathopoulos, EN
机构
[1] Univ Hosp Heraklion, Dept Haematol, Iraklion 71110, Crete, Greece
[2] Univ Hosp Heraklion, Dept Pathol, Iraklion 71110, Crete, Greece
[3] Sotiria Hosp, Med Sch Athens, Dept Internal Med 3, Haematol Unit, Athens 11527, Greece
关键词
D O I
10.1136/jcp.2003.013110
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim: Angiogenesis correlates with disease progression in various haematological malignancies. This study investigated the association between microvascular density (MVD) and the Ki-67 proliferation index (Ki-67 PI), bone marrow infiltration, and C reactive protein (CRP) in patients with multiple myeloma. Methods: Bone marrow MVD was examined in 44 biopsies at diagnosis and 15 in plateau phase by immunostaining the endothelial cells with a monoclonal antibody to CD34. The Ki-67 PI was evaluated by a double immunostaining technique using the monoclonal antibodies MIB-1 and CD38. Results: MVD, Ki-67 PI, bone marrow infiltration, and CRP were significantly higher in pretreatment patients than in controls and decreased in patients achieving plateau phase. MVD significantly correlated with Ki-67 PI and infiltration, and Ki-67 correlated with infiltration. Conclusion: In multiple myeloma, apart from being a marker of proliferative activity, Ki-67 is also associated with bone marrow angiogenesis and tumour burden.
引用
收藏
页码:856 / 860
页数:5
相关论文
共 41 条
[1]   Vascular enumeration as a significant prognosticator for invasive breast carcinoma [J].
Aceñero, MJF ;
González, JF ;
Gallego, MG ;
Ballesteros, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1684-1688
[2]   Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J].
Aguayo, A ;
Kantarjian, H ;
Manshouri, T ;
Gidel, C ;
Estey, E ;
Thomas, D ;
Koller, C ;
Estrov, Z ;
O'Brien, S ;
Keating, M ;
Freireich, E ;
Albitar, M .
BLOOD, 2000, 96 (06) :2240-2245
[3]   Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma [J].
Alexandrakis, MG ;
Passam, FH ;
Boula, A ;
Christophoridou, A ;
Aloizos, G ;
Roussou, P ;
Kyriakou, DS .
ANNALS OF HEMATOLOGY, 2003, 82 (01) :19-23
[4]   The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma [J].
Alexandrakis, MG ;
Passam, FH ;
Ganotakis, ES ;
Sfiridaki, K ;
Xilouri, I ;
Perisinakis, K ;
Kyriakou, DS .
CLINICAL AND LABORATORY HAEMATOLOGY, 2003, 25 (01) :41-46
[5]  
BRUNERI G, 1999, BRIT J CANCER, V81, P1398
[6]  
Chaudhary R, 1999, ANTICANCER RES, V19, P3479
[7]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[8]   THE BIOLOGICAL AND CLINICAL-SIGNIFICANCE OF THE KI-67 GROWTH FRACTION IN MULTIPLE-MYELOMA [J].
DRACH, J ;
GATTRINGER, C ;
GLASSL, H ;
DRACH, D ;
HUBER, H .
HEMATOLOGICAL ONCOLOGY, 1992, 10 (02) :125-134
[9]  
DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
[10]  
2-U